FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034005029> ?p ?o ?g. }

• W2034005029 endingPage "514" @default.
• W2034005029 startingPage "510" @default.
• W2034005029 abstract "Currently, there are few options other than cystectomy for the management of BCG refractory non-muscle invasive bladder cancer. We report our experience with intravesical combination chemotherapy using gemcitabine and MMC in such patients. We identified all patients with non-muscle invasive bladder cancer who were BCG refractory or intolerant and had been treated with intravesical gemcitabine and MMC at our institution. Patients were treated with a combination of intravesical gemcitabine (1000 mg in 50 ml sterile water) followed sequentially by intravesical MMC (40 mg in 20 ml sterile water) every week for 6 weeks (induction). Induction therapy was followed by a maintenance regimen using the same dose of gemcitabine and MMC once a month for 12 months. Data regarding patient demographics and disease information such as previous intravesical therapy, previous cystoscopy, cytology results, time to recurrence, and side effect profile were collected. A total of 10 patients (6 male and 4 female) aged 48 to 85 years (median 67 years) underwent treatment with a median follow-up of 26.5 months (4–34 months). Six patients were recurrence free and have maintained their response at a median of 14 months (4–34 months). Four patients had biopsy proven recurrence. Median time to recurrence was 6 months (range 4–13 months). The therapy was well tolerated in all patients. There were no major complications. Two patients experienced irritative lower urinary tract symptoms, which did not require cessation of therapy and one experienced a maculopapillary rash that improved with benadryl. In patients with recurrent BCG refractory bladder cancer, intravesical combination chemotherapy with gemcitabine and MMC appears to be well tolerated and yields a response in a good proportion number of patients." @default.
• W2034005029 created "2016-06-24" @default.
• W2034005029 creator A5039157270 @default.
• W2034005029 creator A5056969058 @default.
• W2034005029 creator A5064387672 @default.
• W2034005029 creator A5085356399 @default.
• W2034005029 date "2010-09-01" @default.
• W2034005029 modified "2023-10-17" @default.
• W2034005029 title "Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer" @default.
• W2034005029 cites W1572760247 @default.
• W2034005029 cites W1967513395 @default.
• W2034005029 cites W1983989072 @default.
• W2034005029 cites W1991708846 @default.
• W2034005029 cites W1995676112 @default.
• W2034005029 cites W2003915285 @default.
• W2034005029 cites W2012206066 @default.
• W2034005029 cites W2018489324 @default.
• W2034005029 cites W2025383700 @default.
• W2034005029 cites W2037292093 @default.
• W2034005029 cites W2043103956 @default.
• W2034005029 cites W2063940113 @default.
• W2034005029 cites W2087856532 @default.
• W2034005029 cites W2087966393 @default.
• W2034005029 cites W2147633207 @default.
• W2034005029 cites W2148757750 @default.
• W2034005029 cites W2162756611 @default.
• W2034005029 cites W2168579647 @default.
• W2034005029 cites W2333193688 @default.
• W2034005029 cites W2793368320 @default.
• W2034005029 cites W4251083747 @default.
• W2034005029 cites W4321429436 @default.
• W2034005029 doi "https://doi.org/10.1016/j.urolonc.2008.11.019" @default.
• W2034005029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3565601" @default.
• W2034005029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19171491" @default.
• W2034005029 hasPublicationYear "2010" @default.
• W2034005029 type Work @default.
• W2034005029 sameAs 2034005029 @default.
• W2034005029 citedByCount "45" @default.
• W2034005029 countsByYear W20340050292012 @default.
• W2034005029 countsByYear W20340050292013 @default.
• W2034005029 countsByYear W20340050292014 @default.
• W2034005029 countsByYear W20340050292015 @default.
• W2034005029 countsByYear W20340050292016 @default.
• W2034005029 countsByYear W20340050292017 @default.
• W2034005029 countsByYear W20340050292018 @default.
• W2034005029 countsByYear W20340050292019 @default.
• W2034005029 countsByYear W20340050292020 @default.
• W2034005029 countsByYear W20340050292021 @default.
• W2034005029 countsByYear W20340050292022 @default.
• W2034005029 countsByYear W20340050292023 @default.
• W2034005029 crossrefType "journal-article" @default.
• W2034005029 hasAuthorship W2034005029A5039157270 @default.
• W2034005029 hasAuthorship W2034005029A5056969058 @default.
• W2034005029 hasAuthorship W2034005029A5064387672 @default.
• W2034005029 hasAuthorship W2034005029A5085356399 @default.
• W2034005029 hasBestOaLocation W20340050292 @default.
• W2034005029 hasConcept C121332964 @default.
• W2034005029 hasConcept C121608353 @default.
• W2034005029 hasConcept C126322002 @default.
• W2034005029 hasConcept C126894567 @default.
• W2034005029 hasConcept C141071460 @default.
• W2034005029 hasConcept C142424586 @default.
• W2034005029 hasConcept C2775910329 @default.
• W2034005029 hasConcept C2776694085 @default.
• W2034005029 hasConcept C2778769751 @default.
• W2034005029 hasConcept C2780258809 @default.
• W2034005029 hasConcept C2780352672 @default.
• W2034005029 hasConcept C2781413609 @default.
• W2034005029 hasConcept C71924100 @default.
• W2034005029 hasConcept C77411442 @default.
• W2034005029 hasConcept C87355193 @default.
• W2034005029 hasConceptScore W2034005029C121332964 @default.
• W2034005029 hasConceptScore W2034005029C121608353 @default.
• W2034005029 hasConceptScore W2034005029C126322002 @default.
• W2034005029 hasConceptScore W2034005029C126894567 @default.
• W2034005029 hasConceptScore W2034005029C141071460 @default.
• W2034005029 hasConceptScore W2034005029C142424586 @default.
• W2034005029 hasConceptScore W2034005029C2775910329 @default.
• W2034005029 hasConceptScore W2034005029C2776694085 @default.
• W2034005029 hasConceptScore W2034005029C2778769751 @default.
• W2034005029 hasConceptScore W2034005029C2780258809 @default.
• W2034005029 hasConceptScore W2034005029C2780352672 @default.
• W2034005029 hasConceptScore W2034005029C2781413609 @default.
• W2034005029 hasConceptScore W2034005029C71924100 @default.
• W2034005029 hasConceptScore W2034005029C77411442 @default.
• W2034005029 hasConceptScore W2034005029C87355193 @default.
• W2034005029 hasIssue "5" @default.
• W2034005029 hasLocation W20340050291 @default.
• W2034005029 hasLocation W20340050292 @default.
• W2034005029 hasLocation W20340050293 @default.
• W2034005029 hasOpenAccess W2034005029 @default.
• W2034005029 hasPrimaryLocation W20340050291 @default.
• W2034005029 hasRelatedWork W1036257620 @default.
• W2034005029 hasRelatedWork W1988924019 @default.
• W2034005029 hasRelatedWork W2016158856 @default.
• W2034005029 hasRelatedWork W2022399786 @default.
• W2034005029 hasRelatedWork W2044701867 @default.
• W2034005029 hasRelatedWork W2076399298 @default.

• next